glutamic acid has been researched along with phenobarbital sodium in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (14.29) | 18.2507 |
2000's | 7 (50.00) | 29.6817 |
2010's | 5 (35.71) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barinka, C; Hlouchová, K; Konvalinka, J; Lubkowski, J; Majer, P; Mlcochová, P; Plechanovová, A; Rovenská, M; Slusher, BS; Tsukamoto, T | 1 |
Bhardwaj, A; Britton, P; Harukuni, I; Hurn, PD; Jackson, PF; Lu, XC; Potter, BM; Robinson, MB; Slusher, BS; Thomas, AG; Tortella, FC; Traystman, RJ; Vornov, JJ; Wozniak, KM; Yudkoff, M | 1 |
Jackson, P; Lu, M; Slusher, B; Tsukamoto, T; Vornov, JJ; Wang, E; Wozniak, K | 1 |
Dave, JR; Lin, Y; Slusher, BS; Tortella, FC; Ved, H | 1 |
Gafurov, B; Grossfeld, RM; Lieberman, EM; Urazaev, AK | 1 |
Chen, SR; Pan, HL; Slusher, BS; Wozniak, KM | 1 |
Bilak, MM; Coccia, CF; Corse, AM; Rothstein, JD; Slusher, BS; Thomas, AG | 1 |
Long, JB; Meyerhoff, JL; Robinson, MB; Slusher, BS; Yourick, DL | 1 |
Calvin, D; Rojas, C; Slusher, BS; Thomas, AG; Tsukamoto, T; Vornov, J; Wozniak, KM; Wu, Y | 1 |
Ashby, CR; Chun, L; Gardner, EL; Li, J; Li, X; Peng, XQ; Slusher, BS; Thomas, AG; Xi, ZX | 1 |
Raffa, RB; Rawls, SM; Song, K; Tallarida, C | 1 |
Cheong, YH; Jo, SA; Kim, H; Kim, MJ; Lee, SK; Park, SI; Youn, HS | 1 |
Ahn, G; Bing, SJ; Cho, IH; Cho, J; Ha, D; Herath, KH; Jee, Y; Jo, SA; Kim, A; Kim, J; Yu, HS | 1 |
Ishimura, T; Moffett, JR; Neale, JH; Nonaka, T; Yamada, T; Yamamoto, T; Zuo, D | 1 |
1 review(s) available for glutamic acid and phenobarbital sodium
Article | Year |
---|---|
Glutamate carboxypeptidase II (NAALADase) inhibition as a novel therapeutic strategy.
Topics: Analgesics; Animals; Aspartic Acid; Dipeptides; Glutamate Carboxypeptidase II; Glutamic Acid; Humans; Molecular Structure; Neurons; Neuroprotective Agents; Organophosphorus Compounds | 2006 |
13 other study(ies) available for glutamic acid and phenobarbital sodium
Article | Year |
---|---|
Structural insight into the pharmacophore pocket of human glutamate carboxypeptidase II.
Topics: Crystallography, X-Ray; Glutamate Carboxypeptidase II; Humans; Models, Molecular; Molecular Mimicry; Protein Conformation; Recombinant Proteins | 2007 |
Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury.
Topics: Animals; Brain Ischemia; Carboxypeptidases; Culture Techniques; Dipeptides; Disease Models, Animal; Drug Tolerance; Enzyme Inhibitors; Glutamate Carboxypeptidase II; Glutamic Acid; Ischemic Attack, Transient; Mice; Mice, Inbred ICR; Neuroprotective Agents; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Stroke | 1999 |
Blockade of NAALADase: a novel neuroprotective strategy based on limiting glutamate and elevating NAAG.
Topics: Animals; Carboxypeptidases; Dipeptides; Glutamate Carboxypeptidase II; Glutamic Acid; Infarction, Middle Cerebral Artery; Neuroprotective Agents; Organophosphorus Compounds; Rats; Reperfusion Injury | 1999 |
Neuroprotection produced by the NAALADase inhibitor 2-PMPA in rat cerebellar neurons.
Topics: Animals; Carboxypeptidases; Cell Hypoxia; Cell Survival; Cells, Cultured; Cerebellum; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Glutamate Carboxypeptidase II; Glutamic Acid; N-Methylaspartate; Neurons; Neuroprotective Agents; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Veratridine | 2000 |
N-acetylaspartylglutamate (NAAG) is the probable mediator of axon-to-glia signaling in the crayfish medial giant nerve fiber.
Topics: Animals; Aspartic Acid; Astacoidea; Axons; Carboxypeptidases; Cell Communication; Cysteic Acid; Dipeptides; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Glutamate Carboxypeptidase II; Glutamic Acid; Membrane Potentials; N-Methylaspartate; Nervous System; Neuroglia; Organophosphorus Compounds; Receptors, Glutamate; Signal Transduction; Time Factors | 2001 |
Effect of 2-(phosphono-methyl)-pentanedioic acid on allodynia and afferent ectopic discharges in a rat model of neuropathic pain.
Topics: Animals; Behavior, Animal; Carboxypeptidases; Dose-Response Relationship, Drug; Electrophysiology; Enzyme Inhibitors; Glutamate Carboxypeptidase II; Glutamic Acid; Injections, Intravenous; Male; Neurons, Afferent; Neuroprotective Agents; Organophosphorus Compounds; Pain; Rats; Rats, Sprague-Dawley; Sciatic Neuropathy | 2002 |
NAALADase inhibition protects motor neurons against chronic glutamate toxicity.
Topics: Animals; Enzyme Inhibitors; Glutamate Carboxypeptidase II; Glutamic Acid; Motor Neurons; Neuroprotective Agents; Organ Culture Techniques; Organophosphorus Compounds; Rats | 2003 |
Inhibition of glutamate carboxypeptidase II (NAALADase) protects against dynorphin A-induced ischemic spinal cord injury in rats.
Topics: Animals; Anterior Horn Cells; Cell Count; Dose-Response Relationship, Drug; Dynorphins; Glutamate Carboxypeptidase II; Glutamic Acid; Ischemia; Male; Motor Activity; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Spinal Cord; Time Factors | 2005 |
Inhibition of NAALADase by 2-PMPA attenuates cocaine-induced relapse in rats: a NAAG-mGluR2/3-mediated mechanism.
Topics: Amino Acids; Analysis of Variance; Animals; Behavior, Animal; Bridged Bicyclo Compounds, Heterocyclic; Cocaine; Cocaine-Related Disorders; Conditioning, Operant; Corpus Striatum; Dipeptides; Dopamine; Dose-Response Relationship, Drug; Extinction, Psychological; Glutamate Carboxypeptidase II; Glutamic Acid; Male; Microdialysis; Microinjections; Neuroprotective Agents; Nucleus Accumbens; Organophosphorus Compounds; Rats; Rats, Long-Evans; Receptors, Metabotropic Glutamate; Reinforcement Schedule; Self Administration; Sucrose; Sweetening Agents | 2010 |
Glutamate carboxypeptidase II (GCPII) inhibitor displays anti-glutamate and anti-cocaine effects in an invertebrate assay.
Topics: Animals; Cocaine; Glutamate Carboxypeptidase II; Glutamic Acid; Models, Animal; N-Methylaspartate; Organophosphorus Compounds; Pilocarpine; Planarians; Stereotyped Behavior | 2012 |
S1 pocket of glutamate carboxypeptidase II: a new binding site for amyloid-β degradation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Binding Sites; Cell Line, Tumor; Dipeptides; Enzyme Inhibitors; Glutamate Carboxypeptidase II; Glutamic Acid; Humans; Mice; Mice, Transgenic; Molecular Docking Simulation; Mutagenesis, Site-Directed; Organophosphorus Compounds; Proteolysis | 2013 |
Blocking glutamate carboxypeptidase II inhibits glutamate excitotoxicity and regulates immune responses in experimental autoimmune encephalomyelitis.
Topics: Amino Acids; Animals; Astrocytes; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Excitatory Amino Acid Antagonists; Female; Glutamate Carboxypeptidase II; Glutamic Acid; Humans; Immunohistochemistry; Mice; Mice, Inbred C57BL; Organophosphorus Compounds; Protease Inhibitors; Rats, Inbred Lew; Receptors, Metabotropic Glutamate; Spinal Cord; Th1 Cells; Xanthenes | 2016 |
A role for the locus coeruleus in the analgesic efficacy of N-acetylaspartylglutamate peptidase (GCPII) inhibitors ZJ43 and 2-PMPA.
Topics: Analgesics; Animals; Disease Models, Animal; Dopamine beta-Hydroxylase; Excitatory Amino Acid Agents; Formaldehyde; Glutamate Carboxypeptidase II; Glutamic Acid; Locus Coeruleus; Male; Norepinephrine; Organophosphorus Compounds; Pain; Rats; Rats, Sprague-Dawley; Urea | 2017 |